Mesirow Financial Investment Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,905
Closed -$218K 71
2022
Q1
$218K Buy
+5,905
New +$230K 0.73% 77
2021
Q4
Sell
-6,704
Closed -$425K 80
2021
Q3
$425K Sell
6,704
-180
-3% -$13.7K 1.25% 46
2021
Q2
$630K Buy
6,884
+30
+0.4% +$2.38K 1.61% 10
2021
Q1
$467K Sell
6,854
-2,743
-29% -$213K 1.27% 39
2020
Q4
$695K Sell
9,597
-2,215
-19% -$128K 2.2% 4
2020
Q3
$448K Buy
11,812
+68
+0.6% +$2.3K 1.92% 5
2020
Q2
$416K Sell
11,744
-1,146
-9% -$32.6K 1.96% 5
2020
Q1
$281K Buy
+12,890
New +$289K 1.77% 8

Other funds holding CDNA

Mesirow Financial Investment Management's CDNA Position: Q2 2022 in Review

Mesirow Financial Investment Management sold out of CareDx (CDNA) in Q2 2022, closing a stake of 5,905 shares — an estimated $218K sold.

Mesirow Financial Investment Management first reported a position in CDNA in Q1 2020 and held it in 8 quarters. The position peaked at $695K in Q4 2020. 184 funds tracked by Wall St. Rank hold CDNA as of Q2 2022.

  • Mesirow Financial Investment Management reported no remaining CareDx position as of Q2 2022 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 5,905 CareDx shares in Q2 2022, an estimated $218K.
  • Mesirow Financial Investment Management first reported a position in CareDx in Q1 2020 and held it in 8 quarters.
  • Mesirow Financial Investment Management's CareDx position peaked at $695K in Q4 2020.
  • 184 funds tracked by Wall St. Rank held CareDx as of Q2 2022.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2022, filed 20 Jul 2022.